BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 10770626)

  • 1. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
    Walling HW; Swarthout JT; Culver KW
    Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy.
    Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G
    Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C; Bergeron C; Lane D; Garon G; Piché A
    Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice.
    Bi W; Kim YG; Feliciano ES; Pavelic L; Wilson KM; Pavelic ZP; Stambrook PJ
    Cancer Gene Ther; 1997; 4(4):246-52. PubMed ID: 9253510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells.
    Namba H; Iwadate Y; Kawamura K; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2001 Jun; 8(6):414-20. PubMed ID: 11498761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective killing of osteosarcoma cells in culture after retroviral mediated gene transfer of a herpes simplex thymidine kinase suicide gene.
    Grossin L; Charissoux JL; Teissier MP; Rigaud M
    Anticancer Res; 1999; 19(1A):71-6. PubMed ID: 10226526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H; Lu R; Ding R; Kan YW
    Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
    Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V).
    Pavlovic J; Nawrath M; Tu R; Heinicke T; Moelling K
    Gene Ther; 1996 Jul; 3(7):635-43. PubMed ID: 8818652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
    Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
    Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.
    Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
    Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene.
    Kim YG; Bi W; Feliciano ES; Drake RR; Stambrook PJ
    Cancer Gene Ther; 2000 Feb; 7(2):240-6. PubMed ID: 10770632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro and in vivo bystander effect of adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene].
    Gao G; Huang T; Chen S
    Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):301-3. PubMed ID: 12133366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy.
    Park JY; Elshami AA; Amin K; Rizk N; Kaiser LR; Albelda SM
    Gene Ther; 1997 Sep; 4(9):909-17. PubMed ID: 9349427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer 'in vivo'.
    Sacco MG; Benedetti S; Duflot-Dancer A; Mesnil M; Bagnasco L; Strina D; Fasolo V; Villa A; Macchi P; Faranda S; Vezzoni P; Finocchiaro G
    Gene Ther; 1996 Dec; 3(12):1151-6. PubMed ID: 8986442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.